A systematic ethnobotanical review of Adhatoda vasica (L.), Nees.

Adhatoda vasica (L.), Nees belonging to the family Acanthaceae is a shrub with opposite ascending branches. The plant has been used in the indigenous system of medicine in India for near about 2500 years. It is a well-known plant as a drug in Ayurvedic and Unani medicines. Traditionally it was used for the treatment of various acute and chronic diseases and showed strong pharmacological activity particularly for bronchial infections, cough, bacterial infections, reproductive disorders, cardiac diseases and many more. Various phytochemicals like alkaloids, flavonoids, tannins, etc. were obtained from Adhatoda vasica (A. vasica). The active constituent of the plant is vasicine, l-vasicinone, deoxyvasicine, maiontone, vasicinolone and vasicinol etc. This review consists of updated information on the phyto-constituents isolated from A. vasica and their potential role in the treatment of various ailments traditionally and medically. Based on the critical review it was concluded that there is not sufficient scientifically strong evidence to explain that A. vasica extract, could be harmful to human beings especially in pregnant women. Major data on traditional uses as well as toxicological studies, evaluated various correctness, relevance, importance, and reliability for the overall evaluation of A. vasica safety. Numerous clinical trials are conducted around the globe on the herbal formulations of vasaka. This review includes strong data about phytochemical and ethnopharmacological studies that indicate that A. vasica is a versatile native plant of the Indian subcontinent having a commercial reputation and thus can be encouraged for diversified applications like medicinal and other potential uses.

Ethnobotanical and Pharmacological Importance of the Herbal Plants With Anti-Hair Fall and Hair Growth Activities

The primary aim of this study is to access the salient herbal plants with the active constituent of potentially anti-hair fall activities. It also presents the various reasons behind hair loss ailments. As part of this study, a focus is placed on active phytochemicals within these medicinal plants or natural products in terms of various hair fall disease treatments. As natural products have a beneficial effect to minimize hair loss and have promoted the potential for new hair growth, it presents the medicinal values of natural plants in reference to safety and effectiveness for health.

An Overview on Composition and Therapeutic Potentials of the Black Seed (Nigella sativa)

Nigella sativa is an annual herbaceous plant that belongs to the Ranunculaceae family and produces seeds known as black seed or black cumin. Black seed has been used in various civilization around the world for centuries to treat various ailments. It is widely used in a variety of traditional medical systems, including Unani, Ayurveda, and Siddha. Black seed is considered to be nutritionally dense, with high levels of fat, protein, dietary fibre, calcium, and iron. The seed is known to have a wide range of pharmacological properties which are supported by numerous studies. Extensive research has been carried out over decades to confirm the seed’s anti-oxidant, anti-inflammatory, anti-microbial, anti-diabetic, anti-hypertensive, antilipidemic, anti-cancer, gastroprotective, hepatoprotective, neuroprotective properties etc. Black seed has earned a position among the top ranked evidence-based herbal medicines due to its marvellous healing properties. Studies have revealed that the presence of thymoquinone, a major bioactive component of the seed essential oil, is responsible for the majority of its therapeutic properties. Consumption of the seeds for an extended period of time has been shown to have significant effects on lowering blood glucose levels, improving lipid profiles, and other biochemical parameters. The minor or negligible toxicological effects of black seed and its active constituent, thymoquinone, support its long-term use in traditional food and medicine. Because of their low toxicity, black seed is frequently used in food as a flavouring agent, additive in breads, and pickles. The current review summarises the composition, important pharmacological studies, dosage and toxicity of the Blackseed and its application in food industry.

Extraction and Identification of Phenolic Compounds from the Iraqi Heliotropium europaeum L. plant

The plants of genus Heliotropium L. (Boraginaceae) are well-known for containing the toxic metabolites called pyrrolizidine alkaloids (PAs) in addition to the other secondary metabolites. Its spread in the Mediterranean area northwards to central and southern Europe, Asia, South Russia, Caucasia, Afghanistan, Iran, Pakistan, and India, Saudi Arabia, Turkey, and over lower Iraq, Western desert. The present study includes the preparation of various extracts from aerial parts of the Iraqi plant. Fractionation, screening the active constituent, and identification by chromatographic techniques were carried out.Heliotropium europaeum herbs were first defatted with n-hexane then extracted exhaustively by soxhlet apparatus using absolute methanol. The extract was filtered and the solvent was evaporated by applying a reduced pressure by a rotary evaporator. The residue suspended in distilled water and partitioned with chloroform, ethyl acetate, n-butanol. The hydrolysis step was done for the two fractions (n-butanol and ethyl acetate). Phytochemical analysis for the screening and identification of bioactive substances of the Heliotropium europaeum plant was done for each fraction. The identification of n-butanol and ethyl acetate fractions was carried out by thin-layer chromatography (TLC) and HPLC technique. For quantitive analysis, the concentration was calculated by serial concentrations of external standard materials to build a calibration curve between concentration and its equivalent peak area. The outcomes of this study were the identifications of new six phenolic compounds from H. europaeum ethyl acetate fraction, which exhibited wide biological activity. The identified compounds were kaempferol (1), Silybin (2), caffeic acid (3), Genistein (4), Apigenin (5), in addition to syringic acid (6). In the present study, we regard the first to report such results about the phenolic compounds in H. europaeum extract. A total of six discovered phenolics were identified in this extract for the first time. Our results on H. europaeum constituents provide a scientific base to examine the pharmacological effects of this plant in the future.

Risk Assessment of RYR Food Supplements: Perception vs. Reality

Thirty-seven red yeast rice (RYR) food supplements were screened for their mycotoxin and natural statin content. Products included pure RYR capsules and multi-ingredient formulations with standardized amounts of monacolin K (MK), marketed both online and retail in the European Union. In terms of mycotoxins, citrinin (CIT) was found in all the monitored products. As CIT content ranged from 100 to 25100 μg/kg, only four products were compliant with maximum EU levels in force until April 2020, while a single product was compliant with the limit of 100 μg/kg introduced after that date. Four contaminated products were labeled as “citrinin free”. In terms of natural statins, nine products had a lower content vs. label statements (from −30 to −83%), while for 24 a larger MK amount (from 10 to 266%) was noticed. Three products had a negligible MK content and only 19 offered a daily dosage exceeding 10 mg as dictated by the health claim granted by EFSA in the EU. No sample had label values compliant with pharmaceutical Good Manufacturing Practices requirements (95–105% content of active constituent). Variable, but small amounts of simvastatin (0.1–7.5 μg per daily dose) were found in 30 samples. These results suggest that limited efficacy and reported safety issues may stem from an under-regulated and undercontrolled market, weakening both effectiveness and risk assessment evaluations.

Natural Product Chemistry Research in Iraq

Today's west an east scientists developed synthetic drugs but because of problems of the side effects and high cost in addition to resistant developed which not happened in using natural drugs this push the scientist in all over the world to look for new drugs from natural compounds. In Iraq. Since 1980 up today we started a plan led by scientist in Chemistry ,Pharmacology, Physician ,Biology in all universities & medical research centers and we started to develop anew methods for extraction ,isolation,identication of active constituent and trying the active constituent biologicaly and Pharmacologicaly in invitro and invivo on experimental animals . We started screening of more than thousand plants which indigenous in Iraq and take the knowledge from folkloric physician and old information about these from ancient books and references we found around two hundred promising plants we developed methods of extraction , isolation using chromatography and trying to evaluate their efficacy .We managed to prepare drugs to treat warts from ficus caria vitexin from cratagus azorolus, prosoptatin anew antihyperlipidemic drug from prosopis farcta etc. A new method of isolation and identification by new phytochemical methods and new experimental tool for each active constituent are as example how to separate alkaloids, cardiac glycosides inotropic agents , polyphenoles etc. In addition to bacteriological ,toxi-pathological methods then pass to prepare anew natural drugs prepared with highly sophisticated methods and with highly efficiency which may be better than synthetic drugs and more safe .

Nanoformulations of α-Mangostin for Cancer Drug Delivery System

Natural compounds are emerging as effective agents for the treatment of malignant diseases. The active constituent of α-mangostin from the pericarp of Garcinia mangostana L. has earned significant interest as a plant base compound with anticancer properties. Despite α-mangostin’s superior properties as an anticancer agent, its applications are limited due to its poor solubility and physicochemical stability, rapid systemic clearance, and low cellular uptake. Our review aimed to summarize and discuss the nanoparticle formulations of α-mangostin for cancer drug delivery systems from published papers recorded in Scopus, PubMed, and Google Scholar. We investigated various types of α-mangostin nanoformulations to improve its anticancer efficacy by improving bioavailability, cellular uptake, and localization to specific areas These nanoformulations include nanofibers, lipid carrier nanostructures, solid lipid nanoparticles, polymeric nanoparticles, nanomicelles, liposomes, and gold nanoparticles. Notably, polymeric nanoparticles and nanomicelles can increase the accumulation of α-mangostin into tumors and inhibit tumor growth in vivo. In addition, polymeric nanoparticles with the addition of target ligands can increase the cellular uptake of α-mangostin. In conclusion, nanoformulations of α-mangostin are a promising tool to enhance the cellular uptake, accumulation in cancer cells, and the efficacy of α-mangostin as a candidate for anticancer drugs.